Proteins and Peptides

02 Dec 2016 Topline Results of Phase 3 Investigational Study of VONVENDI™ Meets Primary Endpoint Effectively Controlling Bleeding and Blood Loss During Surgical Procedures
01 Dec 2016 Bicycle Therapeutics Announces Broad Partnership with Astrazeneca to Develop Bicyclic Peptides (Bicycles®)
30 Nov 2016 Novo Nordisk A/S: Tresiba® demonstrates a safe cardiovascular profile and reduces the risk of severe hypoglycaemia compared to insulin glargine U100 in the DEVOTE trial
29 Nov 2016 Oramed's ORMD-0901 (Oral GLP-1 Analog) Found Safe and Well Tolerated in Phase Ib Study
29 Nov 2016 Coherus’ Marketing Authorization Application to European Medicines Agency for CHS-1701 (Pegfilgrastim Biosimilar Candidate) Accepted
25 Nov 2016 GSK starts phase III programme with daprodustat for anaemia associated with chronic kidney disease
22 Nov 2016 Intarcia Submits New Drug Application (NDA) to FDA for U.S. Marketing Approval of ITCA 650 in Type 2 Diabetes
22 Nov 2016 Novo Nordisk receives US FDA approval for Xultophy® 100/3.6
22 Nov 2016 Sanofi Receives FDA Approval of Soliqua(TM) 100/33 for the Treatment of Adults with Type 2 Diabetes
19 Nov 2016 Stealth BioTherapeutics Announces Positive Phase 2 Clinical Trial Findings for Patients Undergoing Renal Angioplasty
17 Nov 2016 Endo Announces Positive Data from Phase 2b Study of Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite
16 Nov 2016 CSL Behring Presents Positive Results from the CSL112 AEGIS-I Phase 2b Trial
15 Nov 2016 ERYTECH Announces Withdrawal of Its European Marketing Authorization Application for GRASPA for Acute Lymphoblastic Leukemia and Prepares for Resubmission
14 Nov 2016 Stealth BioTherapeutics Initiates Phase 1 Study of Elamipretide in Dry Age-Related Macular Degeneration
14 Nov 2016 AFSTYLA®, for Haemophilia A, Receives Positive Opinion from European Medicines Agency CHMP
14 Nov 2016 Catalyst Biosciences Announces Positive Preclinical Data with Subcutaneous Dosing of Coagulation Factor IX at ASH Annual Meeting
14 Nov 2016 European Commission Approves Parsabiv™ (etelcalcetide) For The Treatment Of Secondary Hyperparathyroidism In Adults On Hemodialysis
14 Nov 2016 STADA receives “positive opinion” from the EMA for teriparatide biosimilar
11 Nov 2016 Novo Nordisk receives positive opinion from the European regulatory authorities for Fiasp® (fast-acting insulin aspart) for the treatment of diabetes
11 Nov 2016 Sanofi Receives CHMP Recommendation for Approval of SuliquaTM in the EU
10 Nov 2016 Proteon Therapeutics Announces First Patient Dosed in Phase 1 Study Evaluating Vonapanitase for the Treatment of Peripheral Artery Disease Below the Knee
10 Nov 2016 Novo Nordisk submits application in the EU for including data from the two SWITCH trials in Tresiba® label
10 Nov 2016 Amgen Announces Collaboration With Janssen To Co-Fund Studies With KYPROLIS® (Carfilzomib) And DARZALEX® (Daratumumab) In Patients With Multiple Myeloma
10 Nov 2016 Halozyme Announces Broad Clinical Collaboration Agreement To Evaluate PEGPH20 And Tecentriq In Up To Eight Tumor Types
10 Nov 2016 Nektar Therapeutics Presents New Clinical Data from Ongoing Phase 1 Dose-Escalation Study of NKTR-214 at the Society for Immunotherapy of Cancer (SITC) 2016 Annual Meeting

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing